{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34460863",
  "DateCompleted": {
    "Year": "2021",
    "Month": "09",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "09",
    "Day": "20"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "08",
        "Day": "30"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e1009857",
      "10.1371/journal.ppat.1009857"
    ],
    "Journal": {
      "ISSN": "1553-7374",
      "JournalIssue": {
        "Volume": "17",
        "Issue": "8",
        "PubDate": {
          "Year": "2021",
          "Month": "Aug"
        }
      },
      "Title": "PLoS pathogens",
      "ISOAbbreviation": "PLoS Pathog"
    },
    "ArticleTitle": "Binding and entering: COVID finds a new home.",
    "Pagination": {
      "StartPage": "e1009857",
      "MedlinePgn": "e1009857"
    },
    "Abstract": {
      "AbstractText": [
        "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged as a virus with a pathogenicity closer to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and a transmissibility similar to common cold coronaviruses (CoVs). In this review, we briefly discuss the features of the receptor-binding domain (RBD) and protease cleavage of the SARS-CoV-2 spike protein that enable SARS-CoV-2 to be a pandemic virus."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-3208-710X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America."
          }
        ],
        "LastName": "Vu",
        "ForeName": "Michelle N",
        "Initials": "MN"
      },
      {
        "Identifier": [
          "0000-0001-8803-7606"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America."
          },
          {
            "Identifier": [],
            "Affiliation": "Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, United States of America."
          }
        ],
        "LastName": "Menachery",
        "ForeName": "Vineet D",
        "Initials": "VD"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 AI153602",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "AI153602",
        "Acronym": "NH",
        "Agency": "NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R24 AI120942",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "AG049042",
        "Acronym": "NH",
        "Agency": "NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "PLoS Pathog",
    "NlmUniqueID": "101238921",
    "ISSNLinking": "1553-7366"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "spike protein, SARS-CoV-2"
    },
    {
      "RegistryNumber": "EC 3.4.17.23",
      "NameOfSubstance": "Angiotensin-Converting Enzyme 2"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Angiotensin-Converting Enzyme 2"
    },
    {
      "QualifierName": [
        "metabolism",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "pathogenicity",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virus Internalization"
    }
  ],
  "CoiStatement": "The authors have declared that no competing interests exist."
}